6505-01-337-3124 ( CIPRO I.V. , NDC00026-8562-20 , NDC00026-8562-20 , CIPRO )

NSN Information
NSN FSC NIIN Item Name INC
6505-01-337-3124 6505 013373124 CIPROFLOXACIN CONCENTRATE FOR IN 4712
NSN Features
MRC Parameter Characteristics
CXCY PART NAME ASSIGNED BY CONTROLLING AGENCY CIPROFLOXACIN CONCENTRATE FOR INJECTION 20ML VIAL 60S
CRLK PRIMARY CONTAINER CONTENT QUANTITY 20.000 MILLILITERS
CQCT PRIMARY CONTAINER TYPE VIAL
AKJA ACTIVE MEDICAMENT MEDICINAL STRENGTH 200 MILLIGRAMS CIPROFLOXACIN EQUIVALENT
CSCW TOTAL PRIMARY CONTAINER QUANTITY 60
FEAT SPECIAL FEATURES CONTAINS 1 PERCENT AQUEOUS CONCENTRATE OF CIPROFLOXACIN; FOR INTRAVENOUS USE
Manufacturing Part Numbers (SKUs)
Part SKU Cage Status RNVC RNCC SADC DAC RNAAC
CIPRO I.V. 13521 A 1 5 4 KX
NDC00026-8562-20 07HH4 A 2 3 4 ZZ
NDC00026-8562-20 13521 A 9 5 4 KX
CIPRO 13521 A 1 5 4 KX
Manufacturers
Part SKU Cage Manufacturer Type Status
CIPRO I.V. 13521 BAYER PHARMACEUTICALS CORPORATIO A A
NDC00026-8562-20 07HH4 BAYER HEALTHCARE LLC A A
NDC00026-8562-20 13521 BAYER PHARMACEUTICALS CORPORATIO A A
CIPRO 13521 BAYER PHARMACEUTICALS CORPORATIO A A
FLIS Identification
PMIC ADPE Code CRITL Code DEMIL Code DEMIL INTG NIIN Asgt ESD HMIC ENAC Schedule-B INC
A X A 1 04/12/1 Y 3004200060 4712
FLIS Management
MOE REC Rep Code Mgmt Ctl USC Phrase Code Phrase Statement
DS I K U/I CONTAINS 60 EA
DA C2201X- A K U/I CONTAINS 60 EA
DN 9B----- N K U/I CONTAINS 60 EA
DF ------- F K U/I CONTAINS 60 EA
Demilitarization Codes & Management
DML PMI HMIC ADP CC ESDC
A A Y X
Miscellaneous Management
MOE (S_A) SOS AAC QUP UI SLC CIIC RC MCC SVC
DN SMS Y 1 PG M U 9B----- N
DF SMS Y 1 PG M U ------- F
DA SMS Y 1 PG M U C2201X- A
DS SMS Y 1 PG M U D
Management Control Army
MATCAT 1 MATCAT 2 MATCAT 3 MATCAT 4 5 ARC
C 2 2 01 X
Freight
NMFC NMFC SUB UFC HMC LTL LCL WCC TCC SHC ADC ACC ASH NMF DESC
058770 Z 33800 W 532 Z 9 A M Z DRUGS/MEDICINES/VITAMINS NOI